Focus Stocks
Trading Idea: - Is Emerson close to Resistance?
Published on Thursday, 07 June 2012 06:56 Written by TradersHuddle Wire
New York, June 7th (TradersHuddle.com) - Shares of Emerson Electric Co. (NYSE:EMR) are trading very close to calculated resistance at $48.09. The stock ended the trading session at just $45.94, which is near levels that make it difficult to buy or start a position.
Emerson Electric Co. (NYSE:EMR) manufactures and markets electrical, electromechanical, and electronic products and systems. The Company produces a variety of products, including process control, industrial automation, electronics, appliance components, and electric motors. The company was founded in 1890 and is based in St. Louis, Missouri.
Emerson's stock range is defined by its calculated support defined at $44.47 and by the resistance level at $48.09; the stock is clearly over-extended from support, making it harder for participants to establish fresh longs.
Traders don't have a clear entry point for Emerson. However, as the stock pulls back towards $44.47 it will definitely provide a reference point to establish a trade. On the other hand, if the stock breaks above its resistance level at $48.09 then traders will get an opportunity to enter the stock as it moves to a higher range.
Related Articles
- Reference Points for Emerson
- Emerson Is Moving Above Resistance
- Emerson Is Close to Resistance
- Emerson Is Close to the 50 Day Moving Average
- Is Emerson Closing in to Resistance?
- Is Emerson Breaking Out?
- Is Emerson Setting up for a Break Out?
- Is Emerson Expecting Resistance Soon?
- The Range Is Tightening in Emerson
- Emerson Is Approaching its 50 Day Moving Average
Related Partner Headlines
- Emerson Electric Stock To Go Ex-dividend Tomorrow (EMR) - TheStreet.com
- Can Emerson Build On Some Positive Momentum? (EMR, ABB, HON, ETN) - Investopedia
- Emerson Electric Co. Stock Buy Recommendation Reiterated (EMR) - TheStreet.com
- UPDATE: Credit Suisse Reiterates Outperform Rating, Raises PT on Emerson Electric Co. - Benzinga
- Citigroup Reiterates Buy Rating, $55 PT on Emerson Electric Co. - Benzinga
- Emerson Electric's Fourth Quarter Earnings Report - Investopedia
- Emerson Electric Co. (EMR): Today's Featured Industrial Winner - TheStreet.com
- Emerson Electric Fourth Quarter Earnings Preview - Investopedia
- Emerson Electric Co. Stock Buy Recommendation Reiterated (EMR) - TheStreet.com
- Emerson Electric Co. (EMR): Today's Featured Industrial Winner - TheStreet.com
TradersHuddle Search
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Dow Today: Verizon Communications (VZ) Higher - TheStreet.com -
Separating the Bargains From the Busts - TheStreet.com -
Cramer Quick Take: The 60-Inch TV Will Be Key This Holiday - TheStreet.com -
Cramer Quick Take: Cisco Wins If Fiscal Cliff Is Resolved - TheStreet.com -
Gap Up and Sit - TheStreet.com -
Apple, Intel, MicroStrategy: Tech Winners & Losers - TheStreet.com -
Windows 8 PC Sales Disappointing: Report - TheStreet.com -
Cramer Quick Take: Buy Home Depot and Lowe's - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:15,354.40 Trade time:4:40PM EDT Value change:▲121.18 (0.80%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,667.47 Trade time:4:39PM EDT Value change:▲17.00 (1.03%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:3,498.97 Trade time:5:15PM EDT Value change:▲33.73 (0.97%)In The Wires
-
American Recovery Service Donates Hundreds of PCs to School Districts and Boys & Girls Club -
Web HSP Announces Updated Affiliate Programs with Substantially Higher Commissions -
Dissolving Pulp Industry Manufacturers Analysis & 2015 Forecast in New Market Research Report at ReportsnReports.com -
Dr. Bill J. Releford To Speak, Offer Health Screenings at Los Angeles Churches -
Just Published: Cigar Advisor Article by Jonathan Drew, on Boutique Cigars -
Global and China Aerosol Industry Analysis & 2017 Forecasts in New Research Report at RnRMarketResearch.com -
New Telecommunications Upgrade Provides More Capacity for National Corporate Wellness Programs offered by Orriant -
Ventrus Biosciences, Inc. Sued by Investor








